We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clarifies Voluntary Malfunction Summary Reporting Program
FDA Clarifies Voluntary Malfunction Summary Reporting Program
To help manufacturers better understand and make use of the FDA’s four-year-old Voluntary Summary Malfunction Reporting (VMSR) program, the agency released draft guidance on Thursday to explain — but not change — the conditions of the VMSR.